Lupus Clinical Trials
A listing of Lupus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 244 clinical trials
Synergetic B-cell Immunomodulation in SLE - 2nd Study. (SynBioSe-2)
-cell targeting by starting treatment with belimumab (anti-BAFF) followed by rituximab(anti-CD20) in lupus nephritis patients.
- 26 views
- 27 Apr, 2022
- 4 locations
Mediterranean vs. High-Fermented-Food Diet Adherence on Inflammation in Lupus
with Systemic lupus erythematosus (SLE).
- 0 views
- 25 Jul, 2022
- 1 location
ALPN-101 in Systemic Lupus Erythematosus (Synergy)
moderate to severe active systemic lupus erythematosus (SLE)
- 0 views
- 25 Jul, 2022
- 53 locations
Hydroxychloroquine (HCQ) for Recurrent Pregnancy Loss
treatment to improve the chance of a live birth. Exciting indications for using Hydroxychloroquine (HCQ) include: Malaria profylaxis and treatment, systemic and discoid lupus erythematosus (SLE) and
- 97 views
- 01 Mar, 2022
- 1 location
Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus (Tulip SC)
The purpose of this study is evaluating the efficacy and safety of SC antifrolumab in adult patients with moderate -to-severe SLE despite receiving standard therapy
- 0 views
- 14 Jun, 2022
- 66 locations
A Clinical Study to Evaluate the Potential Role of ACTH Gel in Patients With Scleritis (ATLAS)
or on a regular basis (maintenance) in people with systemic lupus erythematosus (lupus), infantile spasms, adults with acute relapses or flares of multiple sclerosis (MS), patients with kidney
- 68 views
- 28 Jul, 2022
- 3 locations
Efficacy and Safety of SAR441344 in the Treatment of Systemic Lupus Erythematosus (APATURA)
treatment of participants aged 18 to 70 years with active Systemic Lupus Erythematosus (SLE). Study details include: Study duration: 36 weeks Treatment duration: 24 weeks
- 0 views
- 24 May, 2022
- 12 locations
A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE) (ISLAND-SLE)
The reason for this study is to see if the study drug LY3471851 (NKTR-358) is safe and effective in adults with systemic lupus erythematosus (SLE).
- 185 views
- 22 Jul, 2022
- 107 locations
A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus
The purpose of this study is to evaluate the efficacy of nipocalimab versus placebo in participants with active systemic lupus erythematosus (SLE).
- 13 views
- 25 Jul, 2022
- 54 locations
A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus Erythematosus (ALLEGORY)
This parallel-group, double-blind, placebo-controlled study will evaluate the efficacy and safety of obinutuzumab versus placebo in participants with active, autoantibody-positive systemic lupus
- 67 views
- 25 Jul, 2022
- 59 locations